MARKET

GNMK

GNMK

GenMark
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.62
+1.45
+11.87%
After Hours: 13.62 +0.01 +0.04% 17:39 09/18 EDT
OPEN
12.32
PREV CLOSE
12.17
HIGH
13.63
LOW
12.32
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
20.88
52 WEEK LOW
3.360
MARKET CAP
967.64M
P/E (TTM)
-24.1915
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average GNMK stock price target is 20.60 with a high estimate of 23.00 and a low estimate of 15.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About GNMK
GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of GenMark Diagnostics, Inc stock information, including NASDAQ:GNMK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNMK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GNMK stock methods without spending real money on the virtual paper trading platform.